Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 20,000 shares at $30.98 ($613K) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($613k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.50 | 7,103 | $217K | 35.4% |
| 2 | $30.50 | 7,103 | $217K | 35.4% |
| 3 | $30.98 | 2,897 | $90K | 14.6% |
| 4 | $30.98 | 2,897 | $90K | 14.6% |
| Total | $30.64 avg | 20,000 | $613K | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-06-18 | $45K | — | Filing → |